DiviDrip · RGEN

RGEN — Repligen Corp

RGEN is Repligen Corp (Healthcare) — a non-dividend-paying stock. Trading at $176.27. Market cap: $9.95B. Capital Quality Rank: 94/100 — Market alpha.

Stock snapshot

Price$176.27
Market cap$9.95B
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)94 / 100 · Market alpha
ROIC (TTM)2.1%
Revenue CAGR (3y)-2.7%
Shareholder buyback yield-1.10%
Altman Z-score zoneSafe

About RGEN

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Listed1986Employees2.0KHQWaltham, MASectorHealthcareWebsiterepligen.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RGEN. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RGEN's current stock price?

RGEN (Repligen Corp) is currently trading at $176.27.

Does RGEN pay a dividend?

RGEN (Repligen Corp) does not currently pay a regular dividend.

What is RGEN's Capital Quality Rank?

RGEN has a Capital Quality Rank of 94/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RGEN in DiviDrip

Add RGEN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow